Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors

Cited by (1,002)

Items 801–900 of 1,002

1. Long-term quality of life and global health following pancreatic surgery for benign and malignant pathologies
   Kaitlin Shaw, Alexander S. Thomas, Vilma L. Rosario, Kazuki N. Sugahara, Beth Schrope, John A. Chabot, Jeanine M. Genkinger, Wooil Kwon, Michael D. Kluger · 2021 · Surgery
2. Does the Microenvironment Hold the Hidden Key for Functional Precision Medicine in Pancreatic Cancer?
   John Kokkinos, Anya Jensen, George Sharbeen, Joshua A. McCarroll, David Goldstein, Koroush Shahsavar Haghighi, Phoebe A. Phillips · 2021 · Cancers
3. Murine Macrophages Modulate Their Inflammatory Profile in Response to Gas Plasma-Inactivated Pancreatic Cancer Cells
   Aydar Khabipov, Eric Freund, Kim Rouven Liedtke, André Käding, Janik Riese, Julia van der Linde, Stephan Kersting, Lars-Ivo Partecke, Sander Bekeschus · 2021 · Cancers
4. Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma
   Yasheen Gao, Melinda Wang, Xiaojia Guo, Joanna Hu, Chen Tian-min, Sade M. B. Finn, Jill Lacy, John W. Kunstman, Charles H. Cha, Melena D. Bellin et al. · 2021 · PLoS ONE
5. Cyst fluid metabolites distinguish malignant from benign pancreatic cysts
   Jiaqi Shi, Zhujun Yi, Lin Jin, Lili Zhao, Alexander B. Raskind, Larisa Yeomans, Zeribe C. Nwosu, Diane M. Simeone, Costas Andreas Lyssiotis, Kathleen A. Stringer et al. · 2021 · Neoplasia
6. MicroRNA‑203‑3p inhibits the proliferation, invasion and migration of pancreatic cancer cells by downregulating fibroblast growth factor 2
   Xifeng Fu, Haichao Zhao, Chang-Zhou Chen, Kang Wang, Fei Gao, Yang-Zhang Tian, Hui-Yu Li, Haoliang Zhao · 2021 · Oncology Letters
7. Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties
   McCubrey, James A., Meher, Akshaya K., Akula, Shaw M., Abrams, Stephen L., Steelman, Linda S., LaHair, Michelle M., Franklin, Richard A., Martelli, Alberto M., Ratti, Stefano, Cocco, Lucio et al. · 2022 · Aging
8. Spectroscopic screening of pancreatic cancer
   K Szymoński, Ewelina W. Lipiec, Kamila Sofińska, Katarzyna Skirlińska‐Nosek, Katarzyna Milian-Ciesielska, Joanna Szpor, Michał Czaja, Sara Seweryn, Natalia Wilkosz, Giovanni Birarda et al. · 2021 · Clinical Spectroscopy
9. Peptide Signatures for Prognostic Markers of Pancreatic Cancer by MALDI Mass Spectrometry Imaging
   Florian Nino Loch, Oliver Klein, Katharina Beyer, Frederick Klauschen, Christian Schineis, Johannes Christian Lauscher, Georgios Antonios Margonis, Claudius E. Degro, Wael Rayya, Carsten Kamphues · 2021 · Biology
10. Wilms Tumor 1-Associated Protein Expression Is Linked to a T-Cell-Inflamed Phenotype in Pancreatic Cancer
    Ji-li Xu · 2022 · Digestive Diseases and Sciences
11. The impact of surgery delay on survival of resectable pancreatic cancer: A systematic review of observational studies
    Maximos Frountzas, Εfstathia Liatsou, Dimitriοs Schizas, Vasilios Pergialiotis, Michail G. Vailas, Neoklis Kritikos, Konstantinos G. Toutouzas · 2022 · Surgical Oncology
12. MYC/Glutamine Dependency Is a Therapeutic Vulnerability in Pancreatic Cancer with Deoxycytidine Kinase Inactivation-Induced Gemcitabine Resistance
    Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Hisayuki Amano, Masahiko Honda, Masahito Kawazu, Hitoshi Okada · 2023 · Molecular Cancer Research
13. Tumor Stroma Area and Other Prognostic Factors in Pancreatic Ductal Adenocarcinoma Patients Submitted to Surgery
    Maria João Amaral, Mariana Amaral, João Sargento Freitas, Rui Caetano Oliveira, Marco Serôdio, Maria Augusta Cipriano, José Guilherme Tralhão · 2023 · Diagnostics
14. Novel Insights Into Immunohistochemical Analysis For Acinar Cell Neoplasm of The Pancreas
    Utako Ishimoto-Namiki, Yoshinori Ino, Minoru Esaki, Kazuaki Shimada, Masayuki Saruta, Nobuyoshi Hiraoka · 2023 · The American Journal of Surgical Pathology
15. Unexplained Acute Distal Pancreatitis: Association With Subsequent Diagnosis of Pancreatic Cancer
    Abraham Fourie Bezuidenhout, Pei-Kang Wei, Deborah Burstein, Alexander Brook, Olga Rachel Brook, Steven D. Freedman, Leo L. Tsai · 2023 · American Journal of Roentgenology
16. Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma
    Prashanth Ashok Kumar, Serenella Serinelli, Daniel J. Zaccarini, Richard S.P. Huang, Natalie A. Danziger, Tyler Janovitz, Alina Basnet, Abirami Sivapiragasam, Stephen L. Graziano, Jeffrey S. Ross · 2023 · Frontiers in Oncology
17. Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherapy
    Astrid Zedlitz Johansen, Sif Ingibergsdóttir Novitski, Jessica Xin Hjaltelin, Susann Theile, Mogens Karsbøl Boisen, Søren Brunak, Daniel Hargbøll Madsen, Dorte Lisbet Nielsen, Inna Markovna Chen · 2023 · Frontiers in Immunology
18. Targeting the Cancer–Neuronal Crosstalk in the Pancreatic Cancer Microenvironment
    Ylenia Capodanno, Michael Hirth · 2023 · International Journal of Molecular Sciences
19. Tumor treating fields: narrative review of a promising treatment modality for cancer
    Tuğçe Kütük, Ece Atak, Alonso La Rosa, Rupesh R Kotecha, Minesh P. Mehta, Michael David Chuong · 2023 · Chinese Clinical Oncology
20. Unified Synthesis and Biological Evaluation of Makaluvamine J and Its Analogs
    Yo Kiichi, Koshiro Fukuoka, Anna Kitano, Koya Ishino, Naoyuki Kotoku · 2024 · Molecules
21. Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer
    Aleksander M. Bogdanski, Jeanin Elise van Hooft, Bas Boekestijn, Bert A. Bonsing, Martin N.J.M. Wasser, Derk C.F. Klatte, Monique Esther van Leerdam · 2024 · Familial Cancer
22. Prognostic significance of collagen signatures in pancreatic ductal adenocarcinoma obtained from second-harmonic generation imaging
    Xiwen Chen, Linying Chen, Jikui Miao, Xingxin Huang, Xiahui Han, Liqin Zheng, Shuoyu Xu, Jianxin Chen, Lianhuang Li · 2024 · BMC Cancer
23. Real‐Time Metabolic Magnetic Resonance Spectroscopy of Pancreatic and Colon Cancer Tumor‐Xenografts with Parahydrogen Hyperpolarized 1‐ 13 C Pyruvate‐d 3
    Lisa M. Fries, Theresa L. K. Hune, Sonja Sternkopf, Salvatore Mamone, Kim Lucia Schneider, Ramona Schulz‐Heddergott, Dorothea Becker, Stefan Glöggler · 2024 · Chemistry - A European Journal
24. Radiogenomic analysis for predicting lymph node metastasis and molecular annotation of radiomic features in pancreatic cancer
    Yi Tang, Yi-xi Su, Jin-mei Zheng, Minling Zhuo, Qing-fu Qian, Qingling Shen, Peng Lin, Zhikui Chen · 2024 · Journal of Translational Medicine
25. Unraveling Pancreatic Cancer: Epidemiology, Risk Factors, and Global Trends
    Rana Muhammad Anss Bin Qadir, Musab Bin Umair, Umar Bin Tariq, Arslan Ahmad, Wajeeha Kiran, M Hasaan Shahid · 2024 · Cureus
26. Recommendations, evidence and sustainability of screening for pancreatic cancer in high-risk individuals
    Aleksander M. Bogdanski, Pilar Acedo, Michael B. Wallace, Monique Esther van Leerdam, Derk C.F. Klatte · 2025 · Best Practice & Research Clinical Gastroenterology
27. Advancing Antibody–Drug Conjugates: Precision Oncology Approaches for Breast and Pancreatic Cancers
    Dhanvin R. Yajaman, Youngman Oh, Jose Gilberto Trevino, Joshua Chuck Harrell · 2025 · Cancers
28. Incidence and Survival Trends of Pancreatic Cancer in Girona: Impact of the Change in Patient Care in the Last 25 Years
    Adelaida Garcia-Velasco, Lluís Zacarías‐Pons, Helena Teixidor, Marc Nathaniel Valeros, Raquel Liñan, Maria Carmen Carmona-Garcia, Montse Puigdemont, Walter Carbajal, Raquel Guardeño, Núria Malats et al. · 2020 · International Journal of Environmental Research and Public Health
29. Providing Appropriate Pancreatic Cancer Care for People Experiencing Homelessness: A Surgical Perspective
    Anna D. Louie, Chibueze A. Nwaiwu, Julia Rozenberg, Debolina Banerjee, Gillian J. Lee, Dewahar Senthoor, Thomas J. Miner · 2021 · American Society of Clinical Oncology Educational Book
30. Heterogeneity in Pancreatic Cancer Fibroblasts—TGFβ as a Master Regulator?
    Dale M. Watt, Jennifer P. Morton · 2021 · Cancers
31. Lipoxins and Resolvins in Patients With Pancreatic Cancer: A Preliminary Report
    Wojciech Błogowski, Katarzyna Dołęgowska, Anna Deskur, Barbara Dołęgowska, Teresa Starzyñska · 2022 · Frontiers in Oncology
32. Impact of Extracellular pH on Apoptotic and Non-Apoptotic TRAIL-Induced Signaling in Pancreatic Ductal Adenocarcinoma Cells
    Sofie Hagelund, Anna Trauzold · 2022 · Frontiers in Cell and Developmental Biology
33. Decreasing length of stay and inpatient mortality associated with pancreatic cancer hospitalizations: A United States national survey from 2008 to 2017
    Dushyant Singh Dahiya, Sumant Inamdar, Abhilash Perisetti, Asim Kichloo, Amandeep Singh, Shantanu Solanki, Dhanshree Solanki, Mohammad Al‐Haddad · 2022 · Pancreatology
34. Anatomy of the neural fibers at the superior mesenteric artery—a cadaver study
    Michael D. Reinehr, Raphael Nicolas Vuille-dit-Bille, Christopher Soll, Anubhav Mittal, Jaswinder Singh Samra, Ralph Fabian Staerkle · 2022 · Langenbeck s Archives of Surgery
35. Natural Products of Marine Origin for the Treatment of Colorectal and Pancreatic Cancers: Mechanisms and Potential
    Nasrin Fares, Tal Luzzatto‐Knaan · 2022 · International Journal of Molecular Sciences
36. Whipple’s operation with a modified centralization concept: A model in low-volume Caribbean centers
    Shamir Omar Cawich, Neil William Pearce, Vijay Naraynsingh, Parul J. Shukla, Rahul Deshpande · 2022 · World Journal of Clinical Cases
37. Pancreatoduodenectomy for suspected malignancy: nonmalignant histology confers increased risk of serious morbidity
    Vasileios K. Mavroeidis, Thomas Brendon Russell, J. Clark, Danielle Adebayo, M. J. Bowles, Christopher D. Briggs, Jemimah L. Denson, Somaiah Aroori · 2022 · Annals of The Royal College of Surgeons of England
38. Availability of Results of Trials Studying Pancreatic Adenocarcinoma over the Past 10 Years
    Anna Pellat, Isabelle Boutron, Philippe Ravaud · 2022 · The Oncologist
39. Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression
    Chunye Zhang, Shuai Liu, Ming Jun Yang · 2022 · World Journal of Gastrointestinal Oncology
40. Immune checkpoint blockade enhances chemophototherapy in a syngeneic pancreatic tumor model
    Sanjana Ghosh, Xuedan He, Wei‐Chiao Huang, Jonathan F. Lovell · 2022 · APL Bioengineering
41. Sphingomyelin synthase 2 is a positive regulator of the CSF1R-STAT3 pathway in pancreatic cancer-associated macrophage
    Shuhua He, Xiang Gu, Jintong Yang, Fei Xu, Jiachun Hu, Wei Wang, Yiheng Huang, Bin Lou, Tingbo Ding, Lu Zhou et al. · 2022 · Frontiers in Pharmacology
42. A multimodal imaging study to highlight elastin-derived peptide pro-tumoral effect in a pancreatic xenograft model
    Lise Nannan, Willy Gsell, Sarah Belderbos, Célia Gallet, Jens Wouters, Sylvie Brassart‐Pasco, Uwe Himmelreich, Bertrand Brassart · 2023 · British Journal of Cancer
43. PANCREATIC CANCER MORTALITY TRENDS AND CORRELATION WITH HUMAN DEVELOPMENT INDEX (HDI) IN BRAZIL OVER 40 YEARS
    Diego Rodrigues Mendonça e Silva, Max Moura de Oliveira, Gisele Aparecida Fernandes, María Paula Curado · 2023 · Arquivos de Gastroenterologia
44. Knowledge, Awareness, and Practices toward Colorectal Cancer and Its Dietary and Lifestyle-Related Risk Factors among Jordanian University Students: A Cross-Sectional Study
    Husam M. Khraiwesh, Dana N. Abdelrahim, Iman Fahmi Mahmoud, MoezAlIslam E. Faris · 2024 · Journal of Cancer Epidemiology
45. Establishment and Characterization of Paired Primary Cultures of Human Pancreatic Cancer Cells and Stellate Cells Derived from the Same Tumor
    Manoj Amrutkar, Emma Kristine Larsen, Monica Aasrum, Anette Vefferstad Finstadsveen, Per Arne Andresen, Caroline Sophie Verbeke, Ivar P. Gladhaug · 2020 · Cells
46. MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers
    Ali Nazarizadeh, Forogh Mohammadi, Fatemeh Alian, Parisa Faraji, Mitra Nourbakhsh, Shahin Alizadeh‐Fanalou · 2020 · OncoTargets and Therapy
47. Pancreatic adenocarcinoma: Beyond first line, where are we?
    Sara Cherri, Silvia Noventa, Alberto Zaniboni · 2021 · World Journal of Gastroenterology
48. Recent developments and applications of quantitative proteomics strategies for high-throughput biomolecular analyses in cancer research
    Hannah N. Miles, Daniel G. Delafield, Lingjun Li · 2021 · RSC Chemical Biology
49. pH-taxis drives aerobic bacteria in duodenum to migrate into the pancreas with tumors
    Hiroaki Shirai, Cocoro Ito, Kosuke Tsukada · 2022 · Scientific Reports
50. Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
    Eva Versteijne, Ignace H. J. T. de Hingh, Marjolein Y.V. Homs, Martijn Intven, Joost M. Klaase, Hjalmar C. van Santvoort, Judith de Vos‐Geelen, Johanna W. Wilmink, Geertjan van Tienhoven · 2022 · Frontiers in Oncology
51. The Impact of Epithelial–Mesenchymal Transition and Metformin on Pancreatic Cancer Chemoresistance: A Pathway towards Individualized Therapy
    Aistė Gulla, Urte Andriusaityte, Gabrielius Zdanys, Elena Babonaite, Kęstutis Strupas, Helena M. Kelly · 2022 · Medicina
52. Association of pancreatic atrophy patterns with intraductal extension of early pancreatic ductal adenocarcinoma: a multicenter retrospective study
    Mika Miki, Atsuhiro Masuda, Mamoru Takenaka, Hideyuki Shiomi, Takao Iemoto, Hidetaka Tsumura, Masahiro Tsujimae, Hirochika Toyama, Keitaro Sofue, Eisuke Ueshima et al. · 2024 · Journal of Gastroenterology
53. Therapeutic targeting of FOSL1 and RELA-dependent transcriptional mechanisms to suppress pancreatic cancer metastasis
    Joana E. Aggrey-Fynn, Meghana Manjunath, Ashish Rajput, Amro M. Abdelrahman, Julia Thiel, Mark Joseph Truty, Andrew G. Clark, Meng Dong, Steven A. Johnsen · 2025 · Cell Death and Disease
54. Stereotactic body radiation therapy for the treatment of locally recurrent pancreatic cancer after surgical resection
    Abhinav V. Reddy, Colin Hill, Shuchi Sehgal, Jin Peng He, Lei Zheng, Joseph M. Herman, Jeffrey John Meyer, Amol Kumar Narang · 2022 · Journal of Gastrointestinal Oncology
55. Molecular characteristics of early‐onset pancreatic ductal adenocarcinoma
    Silvana Debernardi, Łukasz Liszka, Chara Ntala, Katja Steiger, Iréne Esposito, Emanuela Carlotti, Ann‐Marie Baker, Stuart A.C. McDonald, Trevor A. Graham, Branko Dmitrović et al. · 2023 · Molecular Oncology
56. Pectolinarigenin and its derivatives: Bridging the gap between chemical properties and pharmacological applications
    Neeraj Kumar Patel, Rashi Kulshrestha, Asif Ahmad Bhat, Riya Mishra, Neelam Singla, Ritu Mehra Gilhotra, Gaurav Gupta · 2024 · Pharmacological Research - Modern Chinese Medicine
57. Serum and tissue metallome of pancreatic ductal adenocarcinoma
    Sooin Byeon, Taymin du Toit‐Thompson, Luke Hipperson, Sarah Maloney, Ross Wenzel, Anthony James Gill, Jaswinder Singh Samra, Anubhav Mittal, Sumit Sahni · 2024 · Cancer Science
58. Nanoscintillator Coating: A Key Parameter That Strongly Impacts Internalization, Biocompatibility, and Therapeutic Efficacy in Pancreatic Cancer Models
    Clémentine FULBERT, Fréderic Chaput, Sarah Stelse‐Masson, Maxime Henry, Benoît Chovelon, Sylvain Bohic, Dennis Brückner, Jan Garrevoet, Christine Moriscot, Benoît Gallet et al. · 2024 · Small Science
59. Automatic quantification of tumor-stroma ratio as a prognostic marker for pancreatic cancer
    Pierpaolo Vendittelli, John‐Melle Bokhorst, E. Smeets, Valentyna Kryklyva, Lodewijk A.A. Brosens, Caroline Sophie Verbeke, Geert J. S. Litjens · 2024 · PLoS ONE
60. Radiochemotherapy in Pancreatic Cancer
    Małgorzata Domagała-Haduch, Anita Gorzelak-Magiera, Łukasz Michalecki, Iwona Gisterek · 2024 · Current Oncology
61. Small non-coding RNAs and pancreatic ductal adenocarcinoma: Linking diagnosis, pathogenesis, drug resistance, and therapeutic potential
    Ryan N. Fuller, Ann Morcos, Joab Galvan Bustillos, David Caba Molina, Nathan R. Wall · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
62. Pancreatic cancer risk in diabetic patients using the Japanese Regional Insurance Claims
    Tatsunori Satoh, Eiji Nakatani, Hiroyuki Ariyasu, Shinya Kawaguchi, Kazuya Ohno, Hiroshi Itoh, Kaori Hayashi, Takeshi Usui · 2024 · Scientific Reports
63. The value of PET/CT radiomics for predicting survival outcomes in patients with pancreatic ductal adenocarcinoma
    Yeon-koo Kang, Seunggyun Ha, Ji Bong Jeong, So Won Oh · 2024 · Scientific Reports
64. Blood-based biomarkers in pancreatic ductal adenocarcinoma: developments over the last decade and what holds for the future- a review
    Ronit Juthani, Ashish Manne · 2025 · Frontiers in Oncology
65. Biomimetic nanosystems for pancreatic cancer therapy: A review
    Miguel Pereira‐Silva, Francisco Veiga, Ana Cláudia Paiva‐Santos, Ángel Concheiro, Carmen Alvarez‐Lorenzo · 2025 · Journal of Controlled Release
66. Combined phosphorus-32 implantation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer: a propensity score–weighted landmark analysis
    Amanda Huoy Wen Lim, Darshan Nitchingham, Jana Bednarz, Madison Bills, Laxmi Lanka, Berry Allen, Alvin Boon Tee Tan, Rohit Joshi, William Hsieh, Benjamin Crouch et al. · 2025 · Gastrointestinal Endoscopy
67. The Epidemiology of Pancreatic Cancer and the Association With Acetylsalicylic Acid in the United States
    George Khoudari, Motasem M. Alkhayyat, Mohannad Abou Saleh, Emad Mansoor, Muhammad Talal Sarmini, Firas Baidoun, Kenneth J. Vega, Madhusudhan R. Sanaka · 2020 · Pancreas
68. Successful treatment of metastatic pancreatoblastoma in an adult with autologous hematopoietic cell transplant
    Omar Elghawy, John S. Wang, Rachel M. Whitehair, William A. Grosh, Tamila L. Kindwall‐Keller · 2020 · Pancreatology
69. Risk stratification and prognostic factors in patients with unresectable undifferentiated carcinoma of the pancreas
    Hiroshi Imaoka, Masafumi Ikeda, Kosuke Maehara, Kumiko Umemoto, Masato Ozaka, Satoshi Kobayashi, Takeshi Terashima, Hiroto Inoue, Chihiro Sakaguchi, Kunihiro Tsuji et al. · 2021 · Pancreatology
70. PUM1 is upregulated by DNA methylation to suppress antitumor immunity and results in poor prognosis in pancreatic cancer
    Yishi Yang, Xingxing Su, Kaicheng Shen, Chengcheng Zhang, Haisu Dai, Hongbo Ma, Yan Jiang, Ling Shuai, Zhipeng Liu, Jinshan You et al. · 2021 · Translational Cancer Research
71. A pharmacognostic approach for mitigating pancreatic cancer: emphasis on herbal extracts and phytoconstituents
    Shruti Gupta, Atul Kumar, Kiran Kumar Tejavath · 2021 · Future Journal of Pharmaceutical Sciences
72. Molecular advances in pancreatic cancer: A genomic, proteomic and metabolomic approach
    Srujan Rajesh, Michael J Cox, Franscois Runau · 2021 · World Journal of Gastroenterology
73. Light-Inducible Spatio-Temporal Control of TLR4 and NF-κB-Gluc Reporter in Human Pancreatic Cell Line
    Anna Stierschneider, Petra Grünstäudl, Katrin Colleselli, Josef Atzler, Christian Klein, Harald Hundsberger, Christoph Wiesner · 2021 · International Journal of Molecular Sciences
74. Non-pegylated Liposomal Doxorubicin as Palliative Chemotherapy in pre-Treated Advanced Pancreatic Cancer: A Retrospective Analysis of Twenty-Eight Patients
    Konstantin Schlick, Dominik Kiem, Florian Huemer, Daniel Neureiter, Lukas Weiß, Richard Greil · 2021 · Technology in Cancer Research & Treatment
75. Current trends and perspectives in interventional radiology for gastrointestinal cancers
    Elisa Reitano, Nicola de’Angelis, Giorgio Bianchi, Letizia Laera, Stavros Spiliopoulos, Roberto Calbi, Riccardo Memeo, Riccardo Inchingolo · 2021 · World Journal of Radiology
76. Temporality of clinical factors associated with pancreatic cancer: a case-control study using linked electronic health records
    Abu Z M Dayem Ullah, Konstantinos Stasinos, Claude Chelala, Hemant Mahendrakumar Kocher · 2021 · BMC Cancer
77. High‐Throughput Single‐Cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma
    Qinlei Liu, Wenjie Ge, Tongtong Wang, Jiayi Lan, Sandra Martínez‐Jarquín, Christian Wolfrum, Markus Stoffel, Renato Zenobi · 2021 · Angewandte Chemie
78. Inflammatory potential of diet and pancreatic cancer risk in the EPIC study
    Valerie Cayssials, Genevieve Buckland, Marta Crous‐Bou, Catalina Bonet, Elisabete Weiderpass, Guri Skie, Dagfinn Aune, Alicia K. Heath, Therese Haugdahl Nøst, Giovanna Masala et al. · 2022 · European Journal of Nutrition
79. Role and Efficacy of Robotic-assisted Radical Antegrade Modular Pancreatosplenectomy (RAMPS) in Left-sided Pancreatic Cancer
    Eleandros Kyros, Spyridon Davakis, Alexandros Charalabopoulos, Gerasimos S. Tsourouflis, Alexandros Papalampros, Evangelos S. Felekouras, Nikolaos I. Nikiteas · 2022 · Cancer Diagnosis & Prognosis
80. Interferon regulatory factor 5‑induced upregulation of zinc‑finger protein 217 promotes pancreatic carcinoma progression
    Qiao Xiao, Shengxiang Lv, Yan Qiao, Fei Wang, Lin Miao · 2022 · Molecular Medicine Reports
81. Impact of biliary stenting in endoscopic ultrasound‐guided tissue acquisition among patients with pancreatic cancer
    Alexandru Constantinescu, Oana‐Mihaela Plotogea, Mădălina Stan‐Ilie, Tudorel Ciurea, Dan Ionuț Gheonea, Bogdan Silviu Ungureanu, Gheorghe Gh Bălan, Ecaterina Mihaela Rinja, Nikola Panić, Vasile Şandru et al. · 2022 · Journal of Clinical Ultrasound
82. Molecular Mechanisms of miR-214 Involved in Cancer and Drug Resistance
    Elham Karimi, Aghdas Dehghani, Hanieh Azari, Mahboobeh Zarei, Mohammad Shekari, Pegah Mousavi · 2022 · Current Molecular Medicine
83. Discovery of a novel NUAK1 inhibitor against pancreatic cancer
    Myeong-Seong Seo, Kyung Hee Jung, Kewon Kim, Ji Eun Lee, Beom Seok Han, Soyeon Ko, Jae Ho Kim, Sungwoo Hong, So Ha Lee, Soon‐Sun Hong · 2022 · Biomedicine & Pharmacotherapy
84. Pancreatic cancer: Cutaneous metastases, clinical descriptors and outcomes
    Lilly ChunHong Gu, Paras P Mehta, Devika Rao, Veronica M. Rotemberg, Marinela Capanu, Joanne F. Chou, Sabrina T. Lin, Carlie Sigel, Klaus Johannes BUSAM, Lindsay M. Boyce et al. · 2022 · Cancer Medicine
85. Dairy intake and the risk of pancreatic cancer: the Japan Collaborative Cohort Study (JACC Study) and meta-analysis of prospective cohort studies
    Ahmed Arafa, Ehab S. Eshak, Jia-Yi Dong, Kokoro Shirai, Isao Muraki, Hiroyasu Iso, Akiko Tamakoshi, the JACC Study Group · 2021 · British Journal Of Nutrition
86. Natural biodegradable and polymeric nanoparticles for the delivery of noscapine for cancer treatment
    Kiran Yadav, Deepak Yadav, Sunil Kumar, Narra Kishore, Mohamed El‐Sherbiny, Rasha Hamed Al‐Serwi, Gamal Othman, Jana Sameer Sendy, Jamal Moideen Muthu Mohamed · 2022 · Biomass Conversion and Biorefinery
87. Pancreatic Cancer in Celiac Disease Patients—A Systematic Review and Meta-Analysis
    Iga Gromny, Katarzyna Neubauer · 2023 · International Journal of Environmental Research and Public Health
88. Variabilities in global DNA methylation and β-sheet richness establish spectroscopic landscapes among subtypes of pancreatic cancer
    K Szymoński, Ewelina W. Lipiec, Kamila Sofińska, Katarzyna Skirlińska‐Nosek, Michał Czaja, Sara Seweryn, Natalia Wilkosz, Giovanni Birarda, Federica Piccirilli, Lisa Vaccari et al. · 2023 · European Journal of Nuclear Medicine and Molecular Imaging
89. Prognostic Role of Geriatric Nutritional Risk Index in Patients with Pancreatic Cancer: A Meta-Analysis
    Lili Li, Junjun He · 2023 · Nutrition and Cancer
90. Whipple's procedure for pancreatic cancer: training and the hospital environment are more important than volume alone
    Shamir Omar Cawich, Robyn Cabral, Jacintha Douglas, Dexter A Thomas, Fawwaz Mohammed, Vijay Naraynsingh, Neil William Pearce · 2023 · Surgery in Practice and Science
91. Precision oncology: Artificial intelligence, circulating cell‐free DNA, and the minimally invasive detection of pancreatic cancer—A pilot study
    Ray O Bahado-Singh, Onur Türkoğlu, Buket Aydas, Sangeetha Vishweswaraiah · 2023 · Cancer Medicine
92. Meta-analysis of adjuvant chemotherapy versus no adjuvant chemotherapy for resected stage I pancreatic cancer
    Daisy Evans, Nader Ghassemi, Shahab Hajibandeh, Shahin Hajibandeh, Saleh Romman, Richard W. Laing, Damien Durkin, Tejinderjit Athwal · 2023 · Surgery
93. Garcinol in gastrointestinal cancer prevention: recent advances and future prospects
    Nitika Patwa, Ritu Chauhan, Abhishek Pratap Singh Chauhan, Manoj Kumar, Seema Ramniwas, Darin Mansor Mathkor, Adesh Kumar Saini, Hardeep Singh Tuli, Shafiul Haque, Petr Sláma · 2024 · Journal of Cancer Research and Clinical Oncology
94. The association of Helicobacter pylori with pancreatic cancer
    Shria Kumar, David C. Metz, David Edward Kaplan, David Seth Goldberg · 2020 · GastroHep
95. Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer
    Tanzeel Khan, Alan Michael Seddon, Angus George Dalgleish, Said Abdullah Khelwatty, Nikolaos Ioannou, Satvinder Mudan, Helmout Modjtahedi · 2020 · Oncology Reports
96. The role of viruses in adenocarcinoma development
    Mohsen Nakhaie, Javad Charostad, Gholam Abbas Kaydani, Ebrahim Faghihloo · 2020 · Infection Genetics and Evolution
97. CORRELATION BETWEEN RADIOACTIVE CESIUM AND THE INCREASE OF PANCREATIC CANCER: A HYPOTHESIS
    S. Venturi · 2020 · Биосфера
98. Outcomes of 5000 pancreatectomies in Korean single referral center and literature reviews
    Yoonhyeong Byun, Yoo Jin Choi, Youngmin Han, Jae Seung Kang, Hongbeom Kim, Wooil Kwon, Jin‐Young Jang · 2021 · Journal of Hepato-Biliary-Pancreatic Sciences
99. Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection
    Abhinav V. Reddy, Colin Hill, Shuchi Sehgal, Ding Ding, Amy Hacker‐Prietz, Jin Peng He, Lei Zheng, Joseph M. Herman, Jeffrey John Meyer, Amol Kumar Narang · 2021 · Radiation Oncology Journal
100. Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial
     Jakob Liermann, Marc Münter, Patrick Naumann, Amir Abdollahi, Robert C Krempien, Juergen Debus · 2022 · Clinical and Translational Radiation Oncology